Claritev Corporation Is Selected By General Dynamics Information Technology To Support CDC?s World Trade Center Health Program

Claritev (CTEV) reported Q2 revenue of $257.5M, up 6.6%, raising full-year guidance to $1B-$1.02B. Adjusted EBITDA rose 1.1% to $155.8M, but net loss narrowed to $59.2M. Free cash flow doubled to $54.6M, yet unrestricted cash fell to $14.4M. Hedge fund ownership increased, and short interest is 9.03%.

Claritev (NYSE:CTEV) reported Q2 No Surprises Act-related revenue growth attributed mainly to one client, with management saying claim mix drove lower charges per claim. Bookings were $30M ACV in Q2 and $74M in H1, exceeding 2025 total and targeting over $100M for FY. FY revenue guidance raised to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M.

Claritev Corp (CTEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. E Claritev Corporation Reports Second Quarter 2026 Results – Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 – Net Loss of $59.2 million – Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 202

BMO Capital initiated coverage on HCA Healthcare (NYSE:HCA) with an Outperform rating and $495 price target, citing growth drivers like demographic trends and digital transformation. HCA trades at $438.16 with $95.43B market cap, and reported Q2 2026 earnings beating estimates but lowered full-year guidance. Analysts have mixed reactions with varied price targets and ratings.

Boeing (BA) secured a $33.4M contract from the U.S. Department of War for C-17 Avionics Integration work, with completion expected by April 2032. The contract, awarded via a sole-source process, addresses obsolescence and maintains lab functionality. Funds were allocated from fiscal 2026 operations and maintenance budgets.

Raytheon Co. won a $105.6M contract modification for missile parts, with work in Tucson, Arizona, and completion by 2027. The contract includes military sales to 30 countries. Funding is allocated from fiscal 2025 missile procurement, Navy weapons procurement, and Foreign Military Sales funds.